FDA New, GMP Do
Clinical Phase II, III Intermediates
GMP Custom synthesis, Full Document
R&D Center: 8000 sq, More than 100 hoods
Pilot Plant: 20000sq, 40 reactors from 5-200L
Manufacturing Site: 800000sq, 40 reactors from 100-5000L
Web: www.eosmedchem.com
This is my R&D youtube: https://youtu.be/r5cJdXKNXHk
| Opiranserin, 1441000-45-8, Opiranserin Intermediate 1916-07-0, stock 390.8g, white powder, assay by HPLC 98.4%, HNMR, LCMS we supply. |
| Opiranserin, 1441000-45-8, Opiranserin Intermediate 884-35-5, stock 406.2g, white powder, assay by HPLC 98.6%, HNMR, LCMS we supply. |
| Opiranserin, 1441000-45-8, Opiranserin Intermediate 14890-75-6, stock 911.7g, white powder, assay by HPLC 99.3%, HNMR, LCMS we supply. |
| Opiranserin, 1441000-45-8, Opiranserin Intermediate 1147-84-8, stock 177.2g, white powder, assay by HPLC 98.8%, HNMR, LCMS we supply. |
| Opiranserin, 1441000-45-8, Opiranserin Intermediate 176445-80-0, stock 790.9g, white powder, assay by HPLC 98.1%, HNMR, LCMS we supply. |
| Opiranserin, 1441000-45-8, Opiranserin Intermediate 1441000-45-8, stock 695.9g, white powder, assay by HPLC 98.5%, HNMR, LCMS we supply. |
